29 November 2018
On 27 November 2018 the Court of Appeal of The Hague in the Netherlands reversed the first instance court’s decision, confirming the validity of AstraZeneca’s patents on their breast cancer drug Faslodex® and reinstating the earlier injunction against Sandoz in PI proceedings. With this decision the Court of Appeal confirms…
Mehr
22 Juli 2021
On 10 June 2021, the German Bundestag approved an amendment to the Patent Act through the Second Patent Law Modernisation Act. In the meantime, the amendment has also been confirmed by the Bundesrat. Disproportionality of Injunctive Relief The core of the amendment to the Patent Act concerns the injunctive relief…
Mehr